Opk Biotech Cambridge, MA - 02141

Opk Biotech is categorized under Commercial Biotechnical Research in Cambridge, MA and active since 2009.

Opk Biotech was established in 2009, and today employs 1 to 4, earning $2.500.000 to $4.999.999 per year. This is a Commercial Biotechnical Research business, which does work in the B2B market, and is classified as a Commercial Biotechnical Research, under code number 3391120 by the NAICS.

If you are seeking more information, feel free to contact W Richard Light, Vice President at the company’s headquarters by writing to 11 Hurley St, Cambridge, Massachusetts MA 02141 or by phoning (617) 234-6500. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Opk Biotech
Contact Person: W Richard Light, Vice President
Address: 11 Hurley St, Cambridge, Massachusetts 02141
Phone Number: (617) 234-6500
Website Address: opkbiotech.com
Annual Revenue (USD): $2.500.000 to $4.999.999
Founded: 2009
Location Type: Headquarters
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Commercial Biotechnical Research
SIC Code: 8731
NAICS Code: 3391120
Share This Business:

Opk Biotech was started in 2009 to provide professional Commercial Biotechnical Research under the SIC code 8731 and NAICS code 3391120. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $2.500.000 to $4.999.999 per annum.

Feel free to contact W Richard Light, Vice President for inquiries that concern Opk Biotech by calling the company number (617) 234-6500, as your correspondence is most welcome. Additionally, the physical location of the headquarters of Opk Biotech can be found at the coordinates 42.368037,-71.078121 as well as the street address 11 Hurley St in Cambridge, Massachusetts 02141.

For its online presence, you may visit Opk Biotech’s website at opkbiotech.com and engage with its social media outlets through on Twitter and on Facebook.